sinc
peptidas
eg
ace
fulfil
endoand
exopeptidas
function
skidgel
term
limit
proteolysi
origin
introduc
linderstromlang
distinguish
restrict
specif
certain
peptidas
particularli
involv
posttransl
modif
proprotein
precursor
random
proteolysi
accompani
protein
degrad
neurath
number
speci
peptidas
identifi
approach
http
meropssangeracuk
distribut
among
five
class
metallo
serin
cystein
aspart
threonin
cystein
serineand
metallopeptidas
repres
major
one
among
three
main
class
known
put
metallopeptidas
consist
repres
across
speci
vari
exampl
trypanosoma
cruzi
mous
human
tabl
two
class
exhibit
greater
divers
rang
number
gene
cystein
proteas
cruzi
mous
human
serin
peptidas
distribut
even
pronounc
cruzi
mous
human
smaller
number
aspart
peptidas
although
key
therapeut
import
eg
band
asecretas
implic
alzheim
patholog
even
less
varieti
number
threonin
peptidas
greater
consist
represent
metallopeptidas
across
speci
probabl
reflect
gener
cellular
function
distinct
catalyt
mechan
requir
water
molecul
activ
dival
metal
ion
commonli
zinc
complet
repertoir
peptidas
express
tissu
organ
refer
protein
degradom
concept
origin
introduc
lopezotin
colleagu
cal
et
al
compar
analysi
mammalian
degradom
reveal
rodent
gener
complex
combin
peptidas
compar
primat
mainli
due
expans
peptidas
famili
involv
reproduct
host
defenc
puent
et
al
author
also
found
sever
gene
implic
reproduct
nutrit
immun
system
function
rat
mous
chimpanze
inactiv
mutat
human
lineag
find
suggest
convers
specif
peptidas
gene
pseudogen
contribut
evolut
human
genom
recent
exampl
pseudogenis
found
gene
human
rella
et
al
approx
onequart
human
inherit
diseas
caus
mutat
proteasecod
gene
http
www
unioviesdegradom
link
metallopeptidas
see
tabl
abnorm
function
gene
implic
divers
patholog
inflammatori
cardiovascular
diseas
cancer
neurodegener
understand
normal
role
enzym
homologu
import
design
novel
select
therapeut
anim
venom
natur
sourc
wide
rang
metallopeptidas
biolog
implic
mouradasilva
et
al
bacteri
toxin
eg
botulinum
tetanu
exert
toxic
action
metalloproteas
case
block
neurotransmitt
releas
proteolysi
synaptobrevin
schiavo
et
al
organ
use
proteolysi
wide
rang
purpos
includ
complet
protein
digest
dietari
protein
sourc
amino
acid
digest
proteas
trypsin
chymotrypsin
pepsin
degrad
structur
compon
eg
extracellular
matrix
matrix
metalloproteas
mmp
intracellular
protein
turnov
import
postmitot
cell
prevent
accumul
malfunct
protein
lysosom
ubiquitinproteasom
system
includ
partial
digest
extern
antigen
immun
surveil
degrad
cyclin
differ
stage
cell
cycl
convers
precursorprotein
final
biolog
activ
structur
zymogen
proenzym
prohormon
cryptic
peptid
ectodomain
shed
initi
modul
cell
signal
highli
specif
proteolysi
regul
g
protein
receptor
signal
proteinaseactiv
receptor
bunnett
nuclear
transcript
event
regul
intramembran
proteolysi
wolf
chapter
predominantli
focu
process
event
utilis
metalloproteas
physiolog
patholog
consequ
process
protein
biosynthesi
involv
proteolyt
process
remov
initi
methionin
signal
peptid
cell
local
signal
propeptid
present
primari
mechan
posttransl
modif
protein
henc
cotransl
remov
ntermin
methionin
nascent
protein
process
ultim
determin
halflif
protein
expos
new
ntermin
residu
origin
propos
varshavski
colleagu
nend
rule
bachmair
et
al
protein
retain
initi
methionin
shorter
halfliv
frottin
et
al
led
definit
specif
protein
degrad
signal
degron
allow
rapid
degrad
ubiquitinproteasom
system
eukaryot
clpap
proteas
bacteria
ravid
hochstrass
mogk
et
al
initi
step
methionin
remov
catalys
methionyl
aminopeptidas
metap
although
eukaryot
metap
origin
thought
cobaltdepend
like
physiolog
relev
cation
enzym
zinc
bradshaw
et
al
leopoldini
et
al
methionin
remov
subsequ
follow
modif
ntermin
residu
often
crucial
function
dysfunct
protein
context
posttransl
convers
ntermin
glutam
cycliz
form
pyroglutamyl
rel
common
catalys
zinc
metalloenzym
glutaminyl
cyclas
qc
huang
et
al
modifi
among
substrat
alzheim
amyloidb
ab
peptid
render
hydrophob
greater
propens
aggreg
cyni
et
al
small
molecul
inhibitor
qc
may
provid
novel
therapeut
treatment
ad
schill
et
al
see
sect
known
metallopeptidas
divid
clan
accord
structur
catalyt
similar
exampl
type
number
metal
ion
requir
activ
rawl
barrett
also
subdivid
distinct
class
human
genom
practic
class
present
chapter
shall
focu
zinc
metallopeptidas
famili
belong
one
clan
name
sinc
princip
involv
cellsurfac
extracellular
posttransl
modif
protein
peptid
repres
clan
requir
zinc
activ
often
refer
zincin
contain
histidin
residu
zinc
ligand
typic
zinc
bind
motif
hisgluxaaxaahi
hexxh
subdivid
accord
natur
third
zinc
ligand
gluzincin
use
glutamyl
residu
lie
amino
acid
ctermin
hexxh
motif
metzincin
use
asp
within
extend
zinc
motif
hexxhxxgxxhd
term
metzincin
strictli
conserv
methioninecontain
turn
metturn
structur
thought
provid
hydrophob
base
zincbind
site
et
al
metallopeptidas
famili
consid
particular
detail
famili
typifi
neprilysin
neutral
endopeptidas
nep
ii
famili
repres
angiotensinconvert
enzym
peptidyl
dipeptidas
ace
iii
matrix
metallopeptidas
mmp
includ
collagenas
gelatinas
final
shall
consid
relat
adam
disintegrin
metalloproteinas
famili
involv
shed
surfac
protein
includ
adam
thrombospondin
motif
adamt
famili
play
particular
role
extracellular
matrix
turnov
arthriti
jone
riley
member
famili
serv
potenti
drug
target
particularli
cardiovascular
diseas
cancer
recent
provid
insight
mechan
involv
neurodegener
neuroinflamm
especi
point
view
process
amyloid
precursor
protein
app
product
alzheim
diseas
metallopeptidas
utilis
singl
zinc
ion
activ
exampl
two
zinc
ion
requir
cocatalyt
binuclear
process
first
exampl
discov
cytosol
enzym
leucyl
aminopeptidas
burley
et
al
key
function
enzym
trim
proteasomeproduc
peptid
class
antigen
present
upregul
cytokin
eg
ginterferon
beninga
et
al
anoth
exampl
key
pathophysiolog
signific
type
ii
membran
glycoprotein
glutam
carboxypeptidas
ii
gcpii
naaladas
two
distinct
role
brain
inactiv
neuropeptid
nacetylaspartylglutam
cleav
alink
glutam
wherea
intestin
sequenti
releas
glink
glutam
folylpolygglutam
folat
hydrolas
activ
also
ident
prostat
cancer
marker
psma
prostatespecif
membran
antigen
highli
express
aggress
prostat
tumour
might
provid
target
immunolog
therapeut
approach
diseas
et
al
recent
structur
solut
catalyt
inact
mutant
gcpii
complex
substrat
nacaspglu
first
time
reveal
detail
reaction
mechan
dual
zinccontain
metallopeptidas
et
al
brief
select
overview
characterist
metallopeptidas
famili
discuss
herein
follow
detail
descript
individu
peptidas
role
peptid
protein
modif
health
diseas
full
descript
class
categori
metallopeptidas
reader
consult
rawl
barrett
famili
contain
angiotensinconvert
enzym
ace
best
known
key
role
process
cascad
reninangiotensin
system
ra
recent
known
member
famili
human
arguabl
ace
better
term
peptidyldipeptidasea
carboxydipeptidas
number
import
substrat
function
addit
process
angiotensin
gener
refer
ace
rel
recent
timescal
vertebr
evolut
ace
gene
underw
intern
duplic
produc
socal
somat
form
enzym
two
catalyt
site
nand
cdomain
similar
show
differ
substrat
specif
inhibitor
sensit
xray
crystal
structur
domain
complex
select
inhibitor
reveal
molecular
basi
select
two
peptid
process
domain
watermey
et
al
use
altern
initi
site
produc
form
ace
singl
catalyt
site
express
exclus
mammalian
testi
critic
male
reproduct
hagaman
et
al
vertebr
known
express
homolog
peptidas
tipni
et
al
whose
action
seem
counterbal
ace
ace
cours
great
import
regul
blood
pressur
convers
decapeptid
angiotensin
vasopressor
octapeptid
angiotensin
ii
remov
ctermin
dipeptid
potent
inhibitor
ace
captopril
lisinopril
henc
highli
effect
antihypertens
agent
menard
patchett
inhibit
tipni
et
al
figur
illustr
similar
ace
counterregulatori
role
angiotensin
metabol
henc
cardiovascular
biolog
notabl
compris
singl
catalyt
metalloproteas
extracellular
domain
transmembran
ctermin
cytoplasm
domain
share
similar
ace
small
membran
protein
collectrin
involv
amino
acid
transport
kidney
danilczyk
et
al
appear
dual
function
protein
sinc
also
involv
amino
acid
transport
interact
collectrinlik
domain
function
proteas
strict
carboxypeptidas
extracellular
acelik
domain
kowalczuk
et
al
also
subvert
act
cellular
receptor
sever
acut
respiratori
syndrom
sar
coronaviru
associ
downregul
surfac
follow
infect
predispos
domain
organis
cellular
topolog
b
ace
isoform
collectrin
schemat
represent
c
proteolyt
process
event
involv
function
reninangiotensin
system
ra
b
ace
isoform
somat
sace
testicular
tace
collectrin
type
integr
membran
protein
signal
peptid
nterminu
short
ctermin
cytoplasm
domain
number
protein
repres
amino
acid
number
sequenc
tace
possess
singl
hexxh
znbind
motif
hemgh
form
activ
site
wherea
sace
possess
two
collectrin
lack
catalyt
site
sequenc
ident
noncatalyt
extracellular
transmembran
cytosol
domain
similar
ace
c
show
process
pathway
ra
protein
precursor
angiotensinogen
amino
acid
human
biolog
activ
angiotensin
peptid
octapeptid
angiotensin
ii
heptapeptid
angiotensin
ace
angiotensinconvert
enzym
nep
neprilysin
type
angiotensin
ii
receptor
type
angiotensin
ii
receptor
ma
angiotensin
receptor
convers
angiotensin
angiotensin
kinet
time
less
favour
convers
angiotensin
ii
angiotensin
rice
et
al
acut
potenti
fatal
lung
injuri
diseas
henc
number
distinct
disord
sar
infect
cardiovascular
diseas
liver
fibrosi
diabet
effect
mediat
impair
angiotensin
peptid
metabol
upregul
express
activ
benefici
turner
peptidas
famili
repres
larg
famili
metzincin
usual
occur
secret
metalloendopeptidas
although
membranebound
form
mammal
enzym
princip
involv
degrad
extracellular
matrix
import
tissu
remodel
repair
henc
trivial
name
collagenas
gelatinas
etc
gener
refer
matrix
metalloproteas
matrixin
mmp
excess
activ
mmp
result
signific
patholog
tissu
damag
seen
exampl
arthrit
condit
matrixin
gener
synthes
inact
precursor
although
differ
exist
activ
mechan
matrixin
proenzym
held
catalyt
inact
state
due
presenc
cystein
switch
van
wart
birkedalhansen
involv
interact
conserv
cystein
propeptid
catalyt
zinc
ion
henc
prevent
bind
activ
crucial
water
molecul
import
cystein
latenc
proenzym
commonli
activ
thiolblock
agent
aminophenylmercur
acet
apma
see
eg
allinson
et
al
like
metallopeptidas
peptidas
famili
inhibit
chelat
agent
mani
potent
inhibitor
batimastat
synthes
possibl
drug
seem
offer
great
prospect
antimetastat
drug
cancer
chemotherapi
although
fail
live
expect
yet
tu
et
al
timp
tissu
inhibitor
metalloproteas
protein
endogen
inhibitor
peptidas
studi
crayfish
digest
enzym
astacin
mammalian
homologu
meprin
bond
beynon
led
subsequ
discoveri
one
largest
famili
metallopeptidas
contain
adamalysin
adam
peptidas
snake
venom
metallopeptidas
reprolysin
mani
relat
enzym
dumermuth
et
al
seal
courtneidg
potenti
involv
inflammatori
condit
number
synthet
inhibitor
describ
although
lack
highli
specif
inhibitor
avail
also
tend
inhibit
mmp
zhang
et
al
delaet
et
al
skotnicki
et
al
member
famili
inhibit
lee
et
al
peptidas
gener
membran
secret
protein
two
key
mammalian
exampl
tumour
necrosi
factora
convert
enzym
tace
import
posttransl
process
certain
membran
protein
also
known
von
willebrand
factor
proteas
activ
normal
prevent
von
willebrand
diseas
prototyp
famili
neprilysin
endopeptidas
neutral
endopeptidas
origin
discov
renal
brush
border
membran
kenni
colleagu
eg
kerr
kenni
subsequ
rediscov
brain
key
neuropeptidedegrad
enzym
enkephalinas
roqu
et
al
matsa
et
al
nep
type
ii
integr
membran
protein
compos
short
cytoplasm
tail
transmembran
region
larg
extracellular
region
fold
two
domain
enclos
larg
central
caviti
contain
catalyt
site
oefner
et
al
ten
cystein
residu
extracellular
domain
conserv
famili
member
involv
intrachain
disulphid
bond
requir
mainten
structur
activ
turner
et
al
nep
import
role
modul
pain
action
enkephalin
peptid
blood
pressur
inactiv
atrial
natriuret
peptid
prostat
cancer
metabol
mitogen
peptid
immun
system
also
ident
common
acut
lymphoblast
leukaemia
antigen
calla
letart
et
al
long
time
known
peptidas
famili
addit
homologu
known
includ
endothelin
convert
enzym
respons
posttransl
process
protein
precursor
endothelin
famili
hypertens
peptid
fig
process
pathway
like
mani
protein
process
event
involv
hormon
neuropeptid
growth
factor
involv
initi
remov
ntermin
signal
prepeptid
gener
physiolog
inact
proprotein
subsequ
process
secretori
pathway
dibas
cleavag
site
activ
form
one
seven
subtilisinlik
proprotein
convertas
includ
furin
rholam
fahi
intracellular
serin
proteas
consid
chapter
endothelin
pathway
like
either
furin
catalys
process
event
blai
et
al
howev
endothelin
process
pathway
unusu
protein
process
event
sinc
product
prohormon
convertas
action
anoth
physiolog
inert
intermedi
term
big
endothelin
turn
convert
vasoact
endothelin
metallopeptidas
first
identifi
potent
endogen
human
vasoconstrictor
known
time
endothelin
system
held
much
hope
develop
novel
cardiovascular
therapeut
inhibitor
promis
yet
fulfil
kirkbi
et
al
detail
bioinformat
analysi
phylogeni
famili
recent
describ
bland
et
al
human
genom
known
contain
least
seven
neprel
enzym
includ
well
close
homologu
nep
term
whytesid
turner
sever
neplik
enzym
yet
orphan
peptidas
recogn
peptid
substrat
invertebr
speci
contain
consider
neplik
proteas
gene
drosophila
involv
event
reproduct
embryogenesi
renal
function
well
behaviour
trait
thoma
et
al
bland
et
al
structur
nep
complex
inhibitor
phosphoramidon
solv
provid
detail
mechanist
insight
similar
differ
two
metallopeptidas
oefner
et
al
schulz
et
al
much
work
toward
develop
select
inhibitor
nep
ece
possibl
cardiovascular
therapeut
synthet
compound
thiorphan
current
specif
potent
inhibitor
nep
roqu
et
al
endogen
physiolog
inhibitor
nep
describ
sialorphin
opiorphin
analges
activ
compar
potenc
morphin
consist
inhibit
enkephalin
inactiv
nep
rougeot
et
al
wisner
et
al
recent
year
much
attent
focus
newli
discov
physiolog
activ
nep
ece
cleav
dibas
endopeptidas
furin
gener
biolog
inact
big
amino
acid
yanagisawa
et
al
big
cleav
trpval
bond
metalloproteinas
releas
amino
acid
activ
contain
intramolecular
disulphid
bond
shown
straight
line
name
abil
degrad
neurotox
alzheim
amyloid
peptid
ab
iwata
et
al
upregul
nep
ece
may
therefor
provid
option
treatment
alzheim
diseas
stimul
clearanc
ab
therapeut
exampl
enhanc
protein
process
belyaev
et
al
homolog
nep
ece
serv
complementari
role
ab
metabol
play
oppos
role
progress
androgeninsensit
prostat
cancer
respect
effect
endothelin
matur
inactiv
nep
fig
henc
upregul
prostat
nep
downregul
could
provid
therapeut
option
untreat
aggress
stage
prostat
cancer
papandr
et
al
dawson
et
al
peptidas
famili
pitrilysin
famili
contain
metalloendopeptidas
vari
specif
physiolog
role
rang
mitochondri
process
peptidas
mpp
insulindegrad
enzym
insulysin
ide
mpp
remov
ntermin
target
signal
mitochondri
precursor
protein
henc
target
nuclearencod
protein
correct
locat
within
mitochondria
ide
play
role
insulin
metabol
also
may
anoth
physiolog
signific
amyloid
ab
degrad
enzym
edland
famili
character
invert
zincbind
domain
hxxeh
rather
hexxh
although
reaction
mechan
similar
name
nucleophil
attack
carbonyl
carbon
peptid
bond
water
molecul
activ
zinc
polar
activ
site
glutam
residu
lack
potent
specif
inhibitor
peptidas
famili
significantli
hinder
studi
physiolog
function
particularli
case
ide
howev
mice
target
delet
ide
gene
show
hyperinsulinaemia
glucos
intoler
well
increas
accumul
ab
brain
support
propos
protein
process
role
enzym
farri
et
al
peptidas
famili
contain
exopeptidas
thought
requir
cocatalyt
ion
cobalt
manganes
either
aminopeptidas
dipeptidylpeptidas
methionyl
aminopeptidas
see
fall
class
although
like
use
zinc
physiolog
cation
structur
relat
xpro
aminopeptidas
aminopeptidas
p
cottrel
et
al
fumagillinrel
angiogenesi
inhibitor
type
ii
methionyl
aminopeptidas
interest
pharmaceut
industri
treatment
solid
tumour
relat
process
enzym
includ
eukaryot
xpro
dipeptidas
play
role
collagen
recycl
defici
result
increas
prolin
dipeptid
toxic
level
myara
et
al
tabl
fig
reciproc
role
metallopeptidas
neprilysin
nep
endothelinconvert
enzym
develop
androgenindepend
prostat
cancer
androgendepend
prostat
cell
epitheli
cell
express
high
level
nep
nep
level
upregul
androgen
also
stimul
epitheli
growth
although
epitheli
cell
produc
mitogen
peptid
inactiv
nep
stimul
cell
growth
stromal
cell
produc
low
level
convert
big
action
oppos
action
nep
androgen
level
low
typic
therapeut
surgic
drug
regim
nep
level
decreas
allow
mitogen
peptid
produc
epitheli
cell
exhibit
growthpromot
effect
also
condit
stromal
cell
express
higher
level
produc
even
encourag
cell
invas
level
increas
epitheli
cell
becom
metastat
longer
influenc
stroma
henc
inhibit
activ
stroma
upregul
activ
nep
epitheli
cell
could
provid
novel
therapeut
strategi
prostat
cancer
manipul
metallopeptidas
level
dht
dihydrotestosteron
nt
bk
grp
mitogen
peptid
neurotensin
bradykinin
gastrinreleas
peptid
respect
presenceabs
androgen
receptor
enzym
mainli
metalloendopeptidas
eukaryot
peptidas
famili
requir
substrat
prenyl
ctermin
motif
known
caax
box
aliphat
residu
lipid
attach
cystein
residu
protein
prenyl
enhanc
membran
associ
protein
human
farnesylatedprotein
convert
enzym
may
import
process
prelamin
farnesyl
protein
cleav
twice
cell
defect
peptidas
gene
incomplet
process
prelamin
accumul
nuclear
envelop
farnesylatedprotein
convert
enzym
perform
second
process
step
prelamin
releas
peptid
contain
prenyl
ctermin
cy
penda
et
al
endopeptidas
believ
degrad
misfold
membran
protein
therebi
help
maintain
integr
mitochondri
inner
membran
kaser
et
al
defici
lamin
compon
nuclear
lamina
lead
abnorm
nuclear
architectur
knockout
farnesylatedprotein
convert
enzym
mice
caus
growth
retard
muscular
dystrophi
prematur
death
bergo
et
al
famili
also
known
site
proteas
famili
repres
peptidas
human
sporul
factor
spoivfb
rsep
peptidas
escherichia
coli
integr
membran
protein
extens
hydrophob
even
within
sequenc
contain
activ
site
residu
indic
cleav
substrat
either
within
membran
close
peptidas
involv
regul
gene
express
twostep
proteolysi
transcript
regul
exampl
follow
initi
cleavag
lumen
golgi
serin
proteas
proteas
bartz
et
al
zinc
metallopeptidas
releas
ntermin
transcript
factor
domain
sterol
regulatori
element
bind
protein
srebp
membranebound
precursor
fig
releas
domain
enter
nucleu
activ
gene
control
cellular
level
cholesterol
phospholipid
zelenski
et
al
bacteri
rsep
peptidas
also
cleav
transmembran
sequenc
seem
like
intramembran
proteolysi
gener
activ
peptidas
famili
relat
cell
regul
signal
structur
bacteri
proteas
reveal
element
unusu
catalyt
mechan
zinc
watermedi
peptid
bond
hydrolysi
occur
hydrophob
environ
lipid
bilay
feng
et
al
intramembran
proteolysi
involv
divers
physiolog
patholog
event
bacteri
sporul
hepat
c
viral
infect
alzheim
diseas
weihofen
martoglio
latter
case
aspart
proteas
gsecretas
catalys
intramembran
proteolyt
process
event
final
step
product
neurotox
amyloid
ab
peptid
see
limit
proteolysi
precursor
protein
prohormon
zymogen
understood
decad
howev
select
proteolysi
cellsurfac
protein
proteas
commonli
refer
secretas
sheddas
recent
discoveri
provid
insight
number
patholog
condit
see
eg
van
goor
et
al
recent
review
first
observ
metalloproteinas
ace
ectoenzym
endotheli
cellsurfac
could
releas
shed
membran
action
anoth
distinct
integr
membran
proteinas
inhibit
edta
henc
presum
metalloenzym
hooper
et
al
henc
solubl
form
ace
found
plasma
use
diagnost
assess
effect
ace
inhibitor
therapi
deriv
result
highli
specif
posttransl
process
membranebound
form
ace
physiolog
function
solubl
ace
downregul
mechan
unknown
although
solubl
ectodomain
could
conceiv
act
ligand
anoth
protein
ace
secretas
subsequ
name
proteolyt
activ
turn
prototyp
fig
schemat
present
twostep
proteolyt
process
sterol
regulatori
element
bind
protein
srebp
precursor
protein
exampl
intramembran
proteolysi
first
srebp
precursor
protein
cleav
within
lumin
loop
two
transmembran
region
membraneanchor
serin
proteas
term
proteas
proteas
cleav
process
protein
within
transmembran
domain
close
cytoplasm
membran
surfac
releas
srebp
transcript
factor
contain
conserv
hexxh
motif
common
metalloproteas
regulatori
cytoplasm
domain
r
srebp
precursor
protein
interact
cholesterolsensor
protein
process
event
activ
cholesterol
level
low
adapt
wolf
famili
membran
protein
secretas
sheddas
caus
releas
specif
membran
protein
normal
cellsurfac
extracellular
medium
hooper
et
al
huovila
et
al
wide
varieti
cellsurfac
protein
cleav
membran
protein
secretas
like
ace
secretas
function
process
divers
cell
fusion
adhes
cell
signal
substrat
includ
receptor
receptor
ligand
cell
adhes
molecul
ectoenzym
cleavag
normal
occur
singl
specif
site
extracellular
domain
close
membran
surfac
case
ace
arg
ser
alfalah
et
al
mani
case
shed
process
inhibit
certain
hydroxam
compound
origin
develop
mmp
inhibitor
eg
batimastat
princip
studi
one
secretas
tumour
necrosi
factora
convert
enzym
tace
caus
posttransl
releas
activ
tnfa
blood
membranebound
precursor
protnf
secretas
mainli
identifi
member
adam
gene
famili
multidomain
membran
protein
gener
alway
metalloproteinas
adhes
activ
seal
courtneidg
one
gene
encod
adam
protein
human
iron
given
first
protein
shed
event
describ
molecular
level
precis
ident
ace
secretas
still
unknown
adam
complex
protein
featur
prodomain
cystein
switch
like
mmp
zinc
metalloproteas
domain
inact
famili
member
disintegrin
domain
involv
adhes
process
cysteinerich
region
egflik
sequenc
transmembran
region
cytoplasm
tail
structur
catalyt
domain
solv
show
mani
similar
typic
aspect
central
fivestrand
bsheet
surround
five
ahelic
includ
metturn
featur
metzincin
proteas
masko
et
al
orth
et
al
subgroup
adam
compris
member
adamt
famili
transmembran
domain
adam
protein
replac
one
thrombospondin
ts
repeat
henc
act
solubl
secret
proteas
also
lack
egf
sequenc
adam
origin
identifi
long
sought
proteas
involv
process
procollagen
procollagen
nendopeptidas
aggrecan
henc
member
proteinas
famili
potenti
therapeut
target
inflammatori
arthrit
condit
fosang
littl
genet
defici
autoimmun
one
member
famili
lead
sever
haematolog
disord
thrombot
thrombocytopen
purpura
failur
process
platelet
protein
von
willebrand
factor
raif
montgomeri
tabl
addit
shed
proinflammatori
cytokin
tnfa
membran
precursor
mani
ligand
egf
receptor
famili
involv
cellular
prolifer
surviv
deriv
membranebound
precursor
adammedi
shed
exampl
includ
heparinbind
egf
hbegf
tgfa
neuregulin
seem
import
exclus
shed
ligand
activ
activ
g
proteinlink
receptor
exampl
thrombin
angiotensin
ii
process
indirect
receptormedi
activ
egf
receptor
adammedi
protein
process
term
transactiv
particular
implic
vascular
remodel
cancer
case
mmp
rather
adam
may
contribut
shed
event
exampl
may
mediat
shed
integrin
subunit
macrophag
ncadherin
also
solubl
ligand
involv
platelet
activ
vaisar
et
al
dwivedi
et
al
et
al
protein
shed
play
part
process
two
key
neuron
protein
involv
neurodegener
prion
protein
alzheim
amyloid
precursor
protein
app
latter
system
serv
final
discuss
protein
process
event
combin
element
adammedi
shed
intramembran
proteolysi
dysregul
cell
signal
cellular
prion
protein
essenti
develop
prion
diseas
occur
glycolipidanchor
membran
form
solubl
secret
form
contribut
prion
shed
intriguingli
shed
indirect
process
act
via
cleav
prion
protein
three
residu
away
site
addit
lipid
anchor
gli
arg
taylor
et
al
howev
shed
process
appear
regul
convers
prion
protein
transmiss
neurotox
form
surprisingli
light
close
involv
develop
dementia
complex
process
app
studi
far
intens
led
number
possibl
therapeut
avenu
involv
manipul
proteas
activ
express
treatment
diseas
current
clinic
trial
sequenti
proteolysi
larg
transmembran
amyloid
precursor
protein
app
two
aspart
proteas
band
gsecretas
releas
solubl
appb
sappb
ectodomain
gener
ctermin
membran
fragment
amino
acid
amyloidb
peptid
ab
togeth
transcript
regul
app
intracellular
domain
aicd
fig
wolf
ab
peptid
origin
identifi
main
constitu
extracellular
neurit
plaqu
character
ad
glenner
wong
master
et
al
led
formul
amyloid
cascad
hypothesi
alzheim
diseas
hardi
higgin
accumul
ab
characterist
featur
ad
prevent
primari
target
therapeut
strategi
lateonset
form
ad
may
primarili
due
defici
ab
clearanc
rather
format
hama
saido
henc
understand
clearanc
mechan
regul
could
fundament
import
provid
novel
approach
ad
treatment
exact
role
ctermin
proteolyt
product
aicd
remain
unclear
controversi
probabl
act
transcript
regul
togeth
apptail
bind
protein
histon
acetyltransferas
hat
cao
belyaev
et
al
fig
well
establish
app
cleav
select
proteas
b
gsecretas
sever
fragment
possess
physiolog
properti
fig
schemat
represent
proteolyt
process
alzheim
amyloid
precursor
protein
app
regul
aicd
nep
gene
express
degrad
ab
peptid
number
intracellular
membranebound
extracellular
solubl
metallopeptidas
app
constitut
transmembran
protein
undergo
proteolyt
cleavag
band
gsecretas
produc
solubl
ectodomain
refer
sappb
neurotox
amyloid
b
peptid
ab
app
intracellular
domain
aicd
ab
properti
form
neurotox
oligom
aggreg
ultim
form
socal
senil
plaqu
one
patholog
hallmark
alzheim
diseas
app
process
pathway
consid
amyloidogen
contrast
cleavag
app
metalloproteinas
asecretas
adam
protein
within
ab
domain
prevent
format
ab
nonamyloidogen
process
lead
format
solubl
ectodomain
sappa
short
peptid
aicd
aicd
bind
neprilysin
nep
promot
activ
neprilysin
express
nep
belyaev
et
al
bind
requir
aicd
stabilis
also
involv
histoneacetyl
transferas
aicd
also
control
express
gene
nep
gene
silenc
histon
deacetyl
hdac
express
nep
inhibit
howev
incub
cell
va
henc
inhibit
hdac
allow
aicd
bind
nep
promot
reactiv
nep
express
belyaev
et
al
nep
cellsurfac
ectopeptidas
turn
degrad
ab
revers
amyloid
plaqu
accumul
ab
also
cleav
ace
matrix
metallopeptidas
mmp
serin
peptidas
plasmin
cleavag
ab
occur
within
cell
cell
surfac
along
neurit
cell
bodi
extracellular
space
nep
plasmin
cleav
monomer
oligomer
form
ab
nalivaeva
et
al
fig
thu
action
aor
bsecretas
produc
largest
product
app
solubl
ectodomain
protein
sapp
sapp
b
play
import
role
prolifer
neuron
cell
develop
nervou
system
caill
et
al
conti
cattaneo
taylor
et
al
metabol
app
undergo
either
amyloidogen
pathway
action
band
gsecretas
product
ab
nonamyloidogen
pathway
app
cleav
asecretas
hooper
turner
asecretas
cleav
app
insid
ab
sequenc
lysin
leucin
posit
prevent
format
ab
peptid
henc
inhibit
amyloidogen
process
app
activ
activ
asecretas
possibl
approach
prevent
ad
lichtenthal
haass
main
candid
asecretas
may
also
particip
indirect
manner
via
allinson
et
al
hooper
turner
constitut
process
secret
sappa
action
asecretas
occur
cell
surfac
parvathi
et
al
howev
regul
asecretas
activ
stimul
cholinerg
agonist
muscarin
carbachol
canetavil
et
al
phorbol
ester
zhu
et
al
report
localis
mainli
intracellularli
jollytornetta
wolf
transgen
mice
express
human
app
moder
neuron
overexpress
shown
reduc
format
ab
prevent
deposit
plaqu
contrast
express
mutant
inact
led
increas
number
size
amyloid
plaqu
brain
transgen
mice
postina
et
al
transgen
mice
lack
gene
lethal
suggest
asecretas
play
import
role
viabil
organ
killar
et
al
although
enzym
import
development
regulatori
role
format
amyloidogen
ab
requir
activ
transmembran
aspart
proteas
band
gsecretas
fig
bsecretas
also
known
biochemistri
cell
biolog
describ
detail
hunt
turner
therapeut
provid
attract
drug
target
ad
sinc
bace
knockout
mice
form
ab
appear
healthi
luo
et
al
numer
approach
undertaken
find
clinic
effect
inhibitor
human
bsecretas
activ
mostli
field
peptidomimet
noncleav
substrat
analogu
hunt
turner
howev
new
endogen
protein
substrat
continu
discov
eg
cleav
membran
protein
pselectin
glycoprotein
membranebound
sialyltransferas
ldlreceptorrel
protein
lrp
caution
need
sinc
bace
may
unexpect
physiolog
role
recent
known
requir
proper
myelin
occur
process
neuregulin
willem
et
al
cytosol
fragment
app
form
bace
substrat
gsecretas
fig
latter
repres
complex
sever
protein
involv
presenilin
protein
catalyt
core
intramembran
proteas
like
protein
repres
differ
catalyt
class
proteinas
aspart
rather
metallo
signal
peptid
peptidas
also
repres
aspart
intramembran
proteas
also
exampl
serinetyp
intramembran
proteas
eg
rhomboid
proteas
wolf
recent
accumul
ab
brain
tissu
thought
irrevers
process
lead
develop
ad
howev
brain
biochem
pathway
elimin
ab
nalivaeva
et
al
last
year
sever
proteas
metalloenzym
nep
ide
well
serin
proteinas
plasmin
found
capabl
degrad
ab
vitro
vivo
leissr
et
al
turner
et
al
act
extracellularli
either
membranebound
nep
solubl
extracellular
protein
ide
plasmin
ide
anomal
term
subcellular
distribut
sinc
larg
cytosol
akiyama
et
al
also
occur
within
organel
mitochondria
peroxisom
well
solubl
secret
form
yet
lack
secretori
signal
sequenc
zhao
et
al
mechan
secret
remain
enigma
term
unconvent
secret
protein
zhao
et
al
figur
show
schemat
ab
peptid
aggreg
proteolyt
degrad
variou
enzym
patholog
downregul
enzym
could
predispos
accumul
ab
develop
ad
thu
possibl
therapeut
approach
treatment
ad
might
chronic
upregul
one
proteas
either
pharmacolog
gene
therapi
approach
proteas
localis
varieti
subcellular
compart
cell
type
brain
remov
ab
prior
accumul
intramembran
proteolysi
well
establish
mechan
gene
regul
action
intracellular
domain
exampl
notch
signal
pathway
role
icd
releas
app
tail
aicd
action
presenilingsecretas
complex
prove
controversi
particularli
case
relat
potenti
feedback
regul
abdegrad
enzym
nep
pardossipiquard
et
al
chen
selko
howev
chromatin
immunoprecipit
studi
establish
nep
express
directli
regul
acetyl
core
histon
nep
promot
mediat
via
aicd
inhibit
histon
deacetyl
histon
deacetylas
inhibitor
anticonvuls
drug
valproat
trichostatin
potenti
nep
express
activ
belyaev
et
al
valproat
treatment
vivo
mice
reduc
amyloid
plaqu
format
qing
et
al
fig
observ
add
grow
bodi
literatur
saha
pahan
fischer
et
al
emphas
potenti
benefici
effect
hdac
inhibitor
treatment
ad
neurodegen
disord
case
manipul
metalloproteas
express
chapter
review
divers
role
metalloproteas
cell
biolog
physiolog
protein
process
describ
aspect
mechan
regul
clear
metalloproteas
repres
import
therapeut
target
cardiovascular
diseas
ace
inhibitor
prime
exampl
also
potenti
inflammatori
diseas
neurodegener
cancer
potenti
target
explor
numer
orphan
metallopeptidas
whose
substrat
function
current
unknown
may
provid
novel
therapeut
opportun
understand
intric
interrelationship
still
major
goal
modern
molecular
cell
biolog
